The latest PV Reliability Workshop highlighted why investing in PV reliability and quality is more important than ever.
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results